“Tau forms in CSF as a reliable biomarker” for PSP

This is a GREAT Italian study (just published last week) on the use of CSF (cerebrospinal fluid) in diagnosing PSP. The researchers found: “Truncated tau production, which selectively affects brainstem neuron susceptibility, can be considered a specific and reliable marker for PSP.”

“A total of 166 subjects were included in the study (21 PSP, 20 corticobasal degeneration syndrome, 44 frontotemporal dementia, 29 Alzheimer disease, 10 Parkinson disease, 15 dementia with Lewy bodies, and 27 individuals without any neurodegenerative disorder). Each patient underwent a standardized clinical and neuropsychological evaluation. In CSF, a semiquantitative immunoprecipitation was developed to evaluate CSF tau 33 kDa/55 kDa ratio. MRI assessment and VBM analysis was carried out.” Researchers concluded that “Tau form ratio was the lowest in progressive supranuclear palsy with no overlap with any other neurodegenerative illness.”

If this can be duplicated and if the clinical diagnoses of the 166 subjects involved in the study can be confirmed on post-mortem analysis, we will have a biomarker for diagnosing PSP.

I’m pretty sure this is the paper that Dr. Golbe was referring to in the PSP/CBD webinar a few weeks ago.

Robin

Neurology. 2008 Oct 29. [Epub ahead of print]

Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.

Borroni B, Malinverno M, Gardoni F, Alberici A, Parnetti L, Premi E, Bonuccelli U, Grassi M, Perani D, Calabresi P, Di Luca M, Padovani A.

From the Centre for Aging Brain and Dementia (B.B., A.A., E.P., A.P.), Department of Neurology, University of Brescia; the Centre of Excellence for Neurodegenerative Disorders and Department of Pharmacological Sciences (M.M., F.G., M.D.), University of Milan; the Section of Clinical Neuroscience (L.P., P.C.), University of Perugia; Department of Neurology (U.B.), University of Pisa; Department of Health Sciences (M.G.), Section of Medical Statistics & Epidemiology, University of Pavia; and the Vita-Salute San Raffaele University and Scientific Institute San Raffaele (D.P.), Milan, Italy.

OBJECTIVE: In CSF, extended (55 kDa) and truncated (33 kDa) tau forms have been previously recognized, and the tau 33 kDa/55 kDa ratio has been found significantly reduced in progressive supranuclear palsy (PSP) vs in other neurodegenerative disorders.

The aim of this study was to evaluate the diagnostic value of the CSF tau form ratio as a biomarker of PSP and to correlate the structural anatomic changes as measured by means of voxel-based morphometry (VBM) to CSF tau form ratio decrease.

METHODS: A total of 166 subjects were included in the study (21 PSP, 20 corticobasal degeneration syndrome, 44 frontotemporal dementia, 29 Alzheimer disease, 10 Parkinson disease, 15 dementia with Lewy bodies, and 27 individuals without any neurodegenerative disorder). Each patient underwent a standardized clinical and neuropsychological evaluation. In CSF, a semiquantitative immunoprecipitation was developed to evaluate CSF tau 33 kDa/55 kDa ratio. MRI assessment and VBM analysis was carried out.

RESULTS: Tau form ratio was significantly reduced in patients with PSP (0.504 +/- 0.284) when compared to age-matched controls (0.989 +/- 0.343), and to patients with other neurodegenerative conditions (range = 0.899-1.215). The area under the curve (AUC) of the receiver operating characteristic analysis in PSP vs other subgroups ranged from 0.863 to 0.937 (PSP vs others, AUC = 0.897, p < 0.0001). VBM study showed that CSF tau form ratio decrease correlated significantly with brainstem atrophy.

CONCLUSIONS: Truncated tau production, which selectively affects brainstem neuron susceptibility, can be considered a specific and reliable marker for PSP. Tau form ratio was the lowest in progressive supranuclear palsy with no overlap with any other neurodegenerative illness.

PubMed ID#: 18971445 (see pubmed.gov for abstract only)

Giving PSPers balance exercises w/and w/o eye exercises

This is an interesting little study done in Beaverton, OR and published last week in the journal “Physical Therapy.”  Ten people with the clinical diagnosis of progressive supranuclear palsy (PSP) were given balance training and eye movement exercises (“treatment group”) while nine people with PSP were given balance training only (“comparison group”).

Results were:

“The within-group analysis revealed significant improvements in stance time and walking speed for the treatment group, whereas the comparison group showed improvements in step length only.”

The abstract is copied below.

Robin
————————————

Physical Therapy 2008 Oct 23. [Epub ahead of print]

Balance and Eye Movement Training to Improve Gait in People With Progressive Supranuclear Palsy: Quasi-Randomized Clinical Trial.

Zampieri C, Di Fabio RP.
Neurological Science Institute, Oregon Health and Science University, Beaverton, OR.

BACKGROUND AND PURPOSE: Although vertical gaze palsy and gait instability are cardinal features of progressive supranuclear palsy (PSP), little research has been done to address oculomotor and gait rehabilitation for PSP.

The purpose of this study was to compare the benefits of a program of balance training complemented with eye movement and visual awareness training versus balance training alone to rehabilitate gait in people with PSP.

Participants Nineteen people moderately affected by the disease were assigned to either a treatment group (balance plus eye movement exercises, n=10) or a comparison group (balance exercises only, n=9) in a quasi-random fashion.

METHODS: The baseline characteristics assessed were diagnosis (possible versus probable), sex, age, time of symptom onset, dementia, and severity of symptoms. Within-group, between-group, and effect size analyses were performed on kinematic gait parameters (stance time, swing time, and step length) and clinical tests 8-ft [2.4-m] walk test and Timed “Up & Go” Test).

RESULTS: The within-group analysis revealed significant improvements in stance time and walking speed for the treatment group, whereas the comparison group showed improvements in step length only. Moderate to large effects of the intervention were observed for the treatment group, and small effects were observed for the comparison group. The between-group analysis did not reveal significant changes for either group.

DISCUSSION AND CONCLUSION: These preliminary findings support the use of eye movement exercises as a complementary therapy for balance training in the rehabilitation of gait in people with PSP and moderate impairments. Additional studies powered at a higher level are needed to confirm these results.

PubMed ID#: 18948373  (see pubmed.gov for the abstract only)
 

Notes from PSP/CBD Webinar (10/14/08)

I thought the webinar was excellent. I hope many of you were able to attend either by the combo of web and phone, or by phone alone (as I did).

Apparently CurePSP intends to post Dr. Golbe’s PowerPoint presentation to its website some time soon. I do not believe a recording of the webinar was made, unfortunately.

“PSP” was mentioned much more often than CBD. It was unclear if some of the information was PSP-only or applied equally to both PSP and CBD. I think each item would need to be addressed with Dr. Golbe.

The following are some notes I took during the presentation. The notes include what I could recall of the questions and answers. If any of you attended the webinar, please share your notes and key take-aways!

There are two types of PSP: Richardson’s Syndrome and PSP-Parkinsonism. The most common type is RS. One-third of those with PSP have PSP-Parkinsonism (PSP-P). PSP-Parkinsonism looks like Parkinson’s Disease. People with PSP-P live longer. They are less likely to have dementia or visual problems, and they are less likely to fall. Those with PSP-P are more likely to experience tremor. (Robin’s note: If the head of the CurePSP Scientific Advisory Board is using the “two types of PSP” terminology, I conclude that it has gained acceptance among PSP experts.)

On average, those with PSP live 7 years after symptom onset. Broken down, those with RS live 5.9 years after symptom onset and those with PSP-P live 9.1 years after symptom onset. On average, those with PSP are diagnosed 3.5 years after symptom onset. This does not allow for much time for treatment. If you have an earlier age of onset, you survive longer.

In order to get people diagnosed earlier, we need to educate MDs. If MDs see unexplained falls, they should immediately think of PSP. MDs should check for eye movement problems.

There’s a list of supportive features. These are not required for a PSP diagnosis. They are simply “common symptoms” that can be “helpful clues” to an MD in making a diagnosis. (Examples: symmetric bradykinesia, retrocollis.)

In all his years caring for those with PSP, Dr. Golbe has never seen someone with Whipple’s Disease, though it is commonly screened for as part of the PSP diagnosis.

A defect in the protein tau causes: 1) disintegration of microtubules, and 2) clumping. The disintegration of microtubules causes problems in the brain. The tau tangles are the result of problems with tau.

There are three key issues in PSP:
1) too much 4-repeat tau is produced.
2) there is too much oxidation. (Rusting is one form of oxidation.) Too much oxidation damages molecules.
3) the mitochondria is not working properly.

These three key issues lead to the creation of tau tangles. Any treatment in PSP likely to have some success in slowing the disease progression needs to effect one of these three key problems.

The incidence of PSP is 1 per 100,000 people. The prevalence of PSP is 6 per 100,000 people. By comparison, Alzheimer’s Disease is 800 per 100,000 people. (Robin’s note: I believe 800 is a prevalence number.) The incidence of CBD is thought to be less than 1 per 100,000 but the incidence and prevalence of CBD have never been studied.

Of the brains at the PSP Brain Bank where the patients was diagnosed in life with PSP, only 70% actually had PSP. Those who were misdiagnosed actually had: CBD (8%), a continuum of DLBD/PD (3%), ALS (1%), and FTD (1%). FTD is “another tau disorder.” (Robin’s note: Some FTD disorders are not tau disorders but are ubiquitin disorders, so Dr. Golbe’s comment is confusing to me.)

In looking at first-degree relatives of those with PSP, 39% showed abnormalities on various rating scales. This 39% figure suggests that something genetic is going on.

There is evidence of environmental toxins. An example of this is tropical fruit. There is currently research going on into the dietary habits of those with PSP.

In research conducted 20 years ago, there was a *slim* suggestion that those with PSP were less likely to be educated, and more likely to be a factory worker or exposed to toxins used on a farm.

We can’t biopsy the brain and diagnose PSP or CBD. Confirmation of the diagnosis is only possible on post-mortem exam of brain tissue. (Robin’s note: It seems that one or two people on the CBGD_support Yahoo!Group have indicated that their loved ones *did* receive a biopsy and CBD was confirmed.)

A research paper will be published soon looking at the use of CSF (cerebrospinal fluid) in diagnosing PSP.

A family with a history of PSP was studied. We know the general location but not the specific gene associated with PSP.

Standard medication given to those with PSP and CBD includes levodopa (Sinemet) and amantadine. Levodopa sometimes helps with the slowness and stiffness. Amantadine can help sometimes for a few months.

Other medication has unproven benefits:
* amitriptyline (Elavil). Due to side effects from this medication, Dr. Golbe has stopped using it.
* ChEIs. Sometimes these help with dementia.
* SSRIs can help disinhibition.
* CoQ10 is focused on slowing the progression of PSP. It does *not* help with symptoms.

Namenda seems to be poorly tolerated in those with PSP.

Not all symptoms progress at the same rate. There is huge variability.

Sense of smell is reduced a little in PSP.

There are PSP animal models in a type of fish, fly, and worm, and in rats.

An ’05 study showed that lithium reduced hyperphosphorylation of tau. The NIH decided to fund a lithium trial in PSP and CBD. No site involved in the study has received approval yet to proceed recruiting patients. It was noted that the info on the NIH-funded lithium trial is not on the curepsp.org website.

CurePSP is funding the PSP Genetics Consortium. The goal was to have 1000 PSP brains to include in the study. They’ve ended up with 1300 brains. This is a DNA study, a genome study.

There was a question about estimating survival time in someone with PSP. Dr. Golbe replied that the best tool for prognosticating is the PSP Rating Scale he developed. Generally, patients decline at a rate of 10-12 points per year. When a patient gets to 70 points, they usually live for six months. Often the issue is the immobility leads to medical complications. (Robin’s note: You can find the PSP Rating Scale on the CurePSP website — https://www.psp.org/materials/rating_scale.pdf I used this with my dad and found it accurate.)

There was a question about the experimental drug Rember that was discussed at a recent Alzheimer’s Disease conference. Dr. Golbe said he and others are skeptical of the results reported at the conference. There are problems with the design of the trial and the data. The analysis was also suspect. The principal investigator of the trial has a conflict of interest.

There was a question about stem cell research. (Robin’s note: I’m not confident I got all of Dr. Golbe’s statements down correctly so if others listened in please help me out here!) Dr. Golbe noted that there are currently no treatment trials for stem cell therapy. We can’t replace all the dead cells in the brain. He said that stem cell therapy in the early stages of PD is relevant to the PSP world. The closest approach with relevance to PSP is to encourage cells to produce chemicals.

Rare disease of PSP affects only 5 or 6 per 100,000 people

My online friend Joe Blanc posted this article about a New Jersey man with progressive supranuclear palsy to the Society for PSP’s Forum recently.

Robin


PSP: A rare disease 
Brain ailment affects only 5 or 6 per 100,000 people, including John Tartis of Glen Gardner
BY Jeff Weber, staff writer
October 14, 2008

You likely have heard of Parkinson’s disease, Alzheimer’s disease and Lou Gehrig’s disease (also known as amyotrophic lateral sclerosis, or ALS).

What do they have in common? Each affects the brain and can cause anything from loss of memory and/or motor function to even death.

But there is another brain disease, one that affects far fewer people — only five or six per every 100,000 — but is just as potent, about which many people are not aware. It’s called progressive supranuclear palsy, or PSP, and like those other diseases, it has no cure.

There are treatments for Parkinson’s, Alzheimer’s and ALS, but none yet exists for PSP. Those suffering from the neurodegenerative ailment must work hard to live through it — usually for six to 10 years, according to the Society for PSP — until finally succumbing to it.

That’s just what 71-year-old John Tartis of Glen Gardner has been doing since being diagnosed with PSP in October 2004.

Tartis doesn’t speak much these days, finding it difficult to join conversations, but he has made one thing clear: “I feel helpless and can’t figure things out anymore.”

Tartis originally was misdiagnosed with Parkinson’s disease — a common occurrence for those with PSP, according to www.curepsp.org — but thanks to neurologist Dr. Lawrence Golbe of Robert Wood University Hospital in New Brunswick, at least he’s aware of what he has.

But that peace of mind still doesn’t help quell myriad symptoms.

“I am tired all the time but can’t sleep at night,” said Tartis, who had a scale of one to 100 devised for him by Golbe to track the progress of the disease. When first diagnosed, Tartis registered at 14. He now is at 63. “I miss being able to fool around with the car and do things myself (because) I can’t move or walk by myself.”

Tartis — a retired Newark Deputy Fire Chief who used to enjoy skiing, golf, tennis, sailing, biking and camping — also suffers from a lack of concentration and often shows disinterest in conversation. Still, he never is unpleasant nor exhibits any level of frustration.

When asked how he’s doing, Tartis simply says, “Good,” and his wife, Carol, believes he doesn’t truly understand that PSP is fatal. In fact, after a few visits to Golbe, Tartis asked, “When am I going to get better?”

Golbe’s response? “There may be a trial some time that you could participate in; otherwise, the disease will slowly progress.”

And it has. Tartis sometimes falls backward. At first, he needed only a cane. Then came a walker and now a wheelchair. He can barely write, and when he does, the penmanship often is illegible. Tartis even has difficulty feeding himself, since he cannot focus or see the food on the plate.

October is National PSP Awareness Month, and the Society for PSP and www.curepsp.org hope to get the word out about their mission of finding treatment and ultimately a cure. If there were a cure, Tartis once again could enjoy the things he loves, such as skiing, instead of watching on TV and saying, “I wish I could still do that.”

More information is available by calling 800-457-4777 or by visit the Web site.

‘When I kept falling over, my wife said I was drunk’ – one man’s battle with PSP

This is a good article in the Daily Mail (London) about a man struggling with progressive supranuclear palsy.

The PSP Association’s chief executive is quoted as follows:

“PSP is a devastating neurological terminal illness, which first steals a person’s balance, then progressively robs them of their ability to walk, talk, eat, drink and see, yet they remain mentally alert. It can best be described as a living hell.  Most people have never heard of this illness, and don’t recognise its symptoms – even among the medical profession. In its early stages, a lot of people feel lethargic and down, and may wrongly be given antidepressants. These may help some patients, but the side-effects may make others feel worse. In one in three cases of misdiagnosis, people are told they have Parkinson’s Disease and given drugs which do not help and have unpleasant side-effects such as hallucinations.”

Robin

———————

www.dailymail.co.uk/health/article-1043666/When-I-kept-falling-wife-said-I-drunk-One-mans-battle-disease-killed-Dudley-Moore.html

‘When I kept falling over, my wife said I was drunk’: One man’s battle with the disease that killed Dudley Moore
By Lesley Gibson for MailOnline
UPDATED: 21:55 EST, 18 August 2008

On a good day, Ray Nind falls five times. In the past year, he’s been rushed to hospital six times to be treated for the resulting injuries – usually cuts to the back of his head that need stitches.

‘When I first began falling, people thought I was drunk,’ says Ray, 56. ‘Even my wife thought I had been drinking. She kept asking if I’d “had a few” on the quiet, but I honestly hadn’t. I didn’t know why I kept falling. Now, fortunately, everyone who knows me is aware I fall because I’m ill.’

Until recently, Ray, who lives in Ilford, Essex, ran a building business, employed more than 20 staff and drove a three-litre Jaguar. ‘Now I just watch TV all day,’ he says. ‘It’s all I can do.’

His wife Jenny, 54, worked alongside him looking after the secretarial side of the business, but is now his full-time carer.

Ray has a brain disease called Progressive Supranuclear Palsy (PSP) for which there is no treatment or cure. One in three people is predisposed to it because of a genetic fault.

While 4,000 Britons are known to be living with PSP, experts believe the real number is nearer 10,000.

The condition affects those over 40, and equal numbers of men and women.

Daily Mail diarist Nigel Dempster died from it in July 2007, aged 65. Comedian Dudley Moore also died from the condition, in March 2002, aged 66.

The cause is unknown – blows to the head and environmental toxins are possible triggers – but the mechanism is understood.

Basically, cells in the brain produce too much of a certain protein, called tau; this causes neurons (nerve cells) to die. Messages can no longer be sent from the brain to certain muscle groups, especially those affecting the legs, speech, swallowing and vision.

The part of the brain that controls mood and personality may also be affected, leading to patients becoming unusually depressed, withdrawn and apathetic, or aggressive and demanding. The condition does not affect intelligence or memory.

A cruel and unknown disease

PSP is a cruel disease – life expectancy is five to eight years from onset. Although there is no cure or treatment for the condition, drugs can be given to alleviate certain symptoms in some patients.

The PSP Association is battling to make both the public and the medical profession more aware of this devastating illness because without early and accurate diagnosis, patients may be given inappropriate drugs and cannot get the information and support they need.

Chief executive Jane Hardy says: ‘PSP is a devastating neurological terminal illness, which first steals a person’s balance, then progressively robs them of their ability to walk, talk, eat, drink and see, yet they remain mentally alert. It can best be described as a living hell.

‘Most people have never heard of this illness, and don’t recognise its symptoms – even among the medical profession. In its early stages, a lot of people feel lethargic and down, and may wrongly be given antidepressants. These may help some patients, but the side-effects may make others feel worse.

‘In one in three cases of misdiagnosis, people are told they have Parkinson’s Disease and given drugs which do not help and have unpleasant side-effects such as hallucinations.’

Personality change

It took ‘only’ 18 months for Ray to receive his diagnosis – shorter than the average diagnosis time of four years. But, initially, his private neurologist put his symptoms down to a stroke.

When Ray’s symptoms worsened, Jenny kept saying it couldn’t be a stroke, but her husband insisted that ‘consultants are supposed to know best’.

In fact, it had been Jenny who first realised something was wrong, in 2001 when Ray started tripping over kerbs, and steps, for no apparent reason.

‘His elderly father had died just before that and I thought he’d been drinking to numb his grief – yet he insisted he hadn’t,’ she recalls.

But it was the change in his personality that alarmed her most. Normally very sociable, Ray wanted to spend more and more time on his own and lost interest in going out.

‘All he wanted to do was watch TV all day,’ says Jenny. ‘Even his choice of programmes had changed. He started watching rubbish, such as low-life chat shows. He also became unusually irritable.’

Behaviour change

Three years ago, she woke up at 5.30am to find Ray had disappeared, taking the car. ‘I was so worried – this just wasn’t the kind of thing he did. When he hadn’t returned at 6am I called him at work.

‘He answered and explained he’d got up at 2.30am and, not realising what time it was, had set off for work. The police had stopped him and accused him of driving erratically. Convinced he’d been drinking, they’d taken him back to the cells, where he’d spent two hours before they released him and he went in to work.’

It was only when Ray’s colleagues voiced their concerns that he consulted a neurologist in April 2005. The doctor agreed something was wrong but was perplexed because brain scans showed no abnormalities.

This is not unusual – PSP cannot be detected on a brain scan. Even when, a few months later, Ray developed slight paralysis and began slurring his speech, it was blamed on a stroke.

Physical damage

Ray was still working part-time, but his business was failing, partly because he was ill and could not give it the attention it needed. His falls were now occurring on a daily basis, too.

‘He’d fall getting out of the car, or opening the boot – always backwards or sideways,’ remembers Jenny. ‘His eyes were also different, as if he were looking up at the ceiling instead of straight at me.’

Ray’s illness was causing his body increasingly serious damage. He fell down some stairs and fractured his vertebra. He scalded himself trying to fill a hot water bottle to ease the pain and needed specialist burns treatment.

In September 2006, after he had fallen on the living room coffee table so badly he needed several stitches, the couple refused to believe the stroke theory any longer.

At their nearest hospital in Romford, Essex, an NHS neurologist examined the numerous MRI scans and notes from the previous few months. He asked Ray to look up and down, count his fingers, walk in a straight line, and questioned him on his physical capabilities.

Acceptance

As PSP does not show up on scans, specialists use symptoms such as regular backward falls and an upward gaze to check for the illness. Finally, five years after the initial symptoms and 18 months after first seeing a doctor, Ray was correctly diagnosed.

Ray recalls: ‘We’d never heard of PSP so Jenny looked it up on the internet when we got home. As we read the information, all my symptoms suddenly made sense. The falling backwards or sideways, slurred speech, changes in personality and difficulty gripping and swallowing were all listed.’

But Ray also read that the illness would worsen, until he became bed-bound and unable to talk. Because of difficulty swallowing, aspirational pneumonia, when food literally goes down the wrong way, is a real problem; it can cause infection in the lungs, which is often fatal.

Ray says: ‘My first thought was: “I’m going to die much sooner than I want to.” Aside from that, I was too shocked and numb to feel anything else. For weeks, we dressed, ate and went about our daily business like zombies. Gradually, we accepted the news.’

With inspiring courage and stoicism, Ray says he has come to terms with the fact he is dying. His mother died in 1994 from motor neurone disease – a neurological disorder with similarities to PSP. But there is not believed to be a genetic link.

‘Jenny and I both realise there’s no point in being in denial,’ he says. ‘There’s no point in saying I’ll get better, because I won’t. So we’ve faced facts. We know I will die, but we try not to think about it.’

However, it isn’t easy. Ray aches all over because the muscles he cannot use properly cramp. His eyes are dry and sore because he cannot blink, and he has double vision because his eye muscles do not get messages from the brain.

With his slurred speech, saying more than a few words is tiring. He struggles to grip his cutlery and needs a wheelchair for outings. ‘It’s very annoying being unable to do anything for myself,’ he says.

Raising awareness

There are times when Ray forgets how incapable he is, and gets up to do something, only to fall and hurt himself. Six weeks ago, he cut his head again after going out unsupervised in his electric wheelchair and falling out.

For Jenny, of course, caring for Ray is a heartrending job. The outgoing, independent man she married 28 years ago must be dressed, washed and fed.

Yet she is incredibly chatty, cheerful and doggedly determined to see the bright side in everything, even if she is despairing inside. ‘We haven’t been to casualty yet this year, and that’s great,’ she jokes.

Although there is no treatment for PSP, Ray takes anti-depressants and sleeping tablets. The couple also have the support of a multidisciplinary team arranged by their GP, including an occupational therapist who has provided them with disability aids, a speech and language therapist to help with communication, and care assistants to help Jenny.

The couple have planned for the future as much as they can. ‘We’ve set up wills and cleared our debts, apart from the mortgage,’ says Jenny. ‘And thanks to the GP, we have the support we need. I just hope that our story is a lesson to other people who might be affected by PSP.

‘We want to make people aware of this illness so they don’t go through what we did. We spent months struggling without any help or support because Ray was misdiagnosed.

‘Although this disease is incurable, knowing what was wrong with Ray was such a relief. It meant we could make sense of his symptoms and get some help.’

For Ray, it’s simply a case of trying to stay strong for as long as he can. ‘It’s very frustrating. I used to be proud to be the one that looked after the family, and now there’s been a complete role reversal. I’m an old-fashioned man and it’s been hard to accept that, but I’ve had to.’